CSIMarket
 
Bausch and Lomb Corp  (NYSE: BLCO)
 
Price: $18.0400 $-0.10 -0.551%
Day's High: $18.170000076293945 Week Perf: 3.2 %
Day's Low: $ 17.86 30 Day Perf: 10.34 %
Volume (M): 414,100 52 Wk High: $ 18.92
Volume (M$): $ 0 52 Wk Avg: $16.28
Open: $17.92 52 Wk Low: $13.77



 Market Capitalization (Millions $) 6,442
 Shares Outstanding (Millions) 357
 Employees 13,000
 Revenues (TTM) (Millions $) 5,324
 Net Income (TTM) (Millions $) -163
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) 321

Business Description


Bausch and Lomb Corporation is a global eye health company based in Rochester, New York. The company was founded in 1853 by John Jacob Bausch and Henry Lomb and has since become a global leader for ophthalmology, vision care products, and biological pharmaceuticals.

The company's mission is to help people see better to live better by delivering innovative eye health products, technologies, and services focused on improving patient outcomes. Bausch and Lomb's products are designed to help people see better, alleviate eye discomfort, and help patients with eye conditions such as glaucoma, retinal diseases, and cataracts.

Bausch and Lomb produces a wide range of eye care products that include prescription and over-the-counter eye drops, contact lenses, lens care products, and surgical equipment for cataract procedures. The company operates in three major businesses:
- Vision Care: This segment includes the company's contact lens and lens care products, as well as prescription and over-the-counter eye drops for dry eye and other eye conditions.
- Pharmaceuticals: The company produces a wide range of ophthalmic pharmaceuticals prescribed for cataract surgery, glaucoma, and other eye conditions.
- Surgical: This segment includes the company's surgical products used for cataract surgery and treatment of retinal diseases.

Bausch and Lomb is known for its innovation in eye health technology. Since its inception, the company has been committed to research and product development, which has resulted in a number of medical breakthroughs. For example, Bausch and Lomb introduced the first soft contact lens in 1971 and the first disposable contact lens in 198 The company has since introduced a wide range of contact lens products tailored to individual needs.

The company has its products available in over 100 countries, and employs more than 13,000 people worldwide. In addition to innovative products and services, Bausch and Lomb also provides education and training for eye care professionals to further their knowledge and expertise.

Overall, Bausch and Lomb is a leading innovator in the eye health industry, a global leader in providing eye care products, and has remained committed to improving patients' vision health for over 150 years.


   Company Address: 520 Applewood Crescent, Zagreb 0 City of Zagreb
   Company Phone Number: 695-7700   Stock Exchange / Ticker: NYSE BLCO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EYE   -3.68%    
FEMY   -6.88%    
NIMU        10% 
STAA        6.15% 
WST        0.74% 
JNJ        2.68% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.21
Price to Sales (Expected) -
Price to Book 1
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.19
Working Capital Ratio 1.5
Leverage Ratio (MRQ) 1.17
Total Debt to Equity 0.79
Interest Coverage (TTM) 2.22
Debt Coverage (TTM) 0.26

Per Share Current
Earnings (TTM) -0.48 $
Revenues (TTM) 14.91 $
Cash Flow (TTM) 0.02 $
Cash 1.03 $
Book Value 18.05 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 409,538
Net Income per Employee (TTM) -12,538
Receivable Turnover Ratio (TTM) 4.65
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.38

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) 5.95 %
Net Margin (MRQ) -0.72 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Bausch And Lomb's Segments
Product    188.52 % of total Revenue
Vision Care Branded and Other Generics    0.72 % of total Revenue
Vision Care    107.25 % of total Revenue
Pharmaceuticals    47.27 % of total Revenue
Surgical    34.72 % of total Revenue
Pharmaceutical Products    40.6 % of total Revenue
Device Products    72.02 % of total Revenue
Over the Counter Products    67.5 % of total Revenue
Branded and Other Generic Products    8.39 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.